BiomarkersHumans
Study of brain perfusion in adults with Down Syndrome along the Alzheimer's Disease continuum
AAIC 2025 Abstract
Abstract
Background: Down Syndrome (DS) represents a high‐risk group for Alzheimer's disease (AD) due to chromosome 21 triplication, which drives amyloid precursor protein overproduction. While brain atrophy in DS has been widely studied, the underlying brain perfusion changes remain poorly understood.


